Safety

Is TRT safe?

An honest answer — not a sales pitch. TRT is a well-established medical treatment with real risks that require real oversight.

The short answer.

For appropriately evaluated and monitored patients, testosterone replacement therapy is a well-established, FDA-recognized treatment with decades of clinical use. It is not risk-free. That's exactly why it requires physician oversight, lab-confirmed diagnosis, and ongoing monitoring — not a subscription and a quiz.

What the evidence says.

Cardiovascular risk

Earlier concerns about cardiovascular risk have been substantially addressed by the TRAVERSE trial (2023), a large randomized controlled trial that found TRT did not increase major cardiovascular events in men with hypogonadism and elevated cardiovascular risk. Monitoring remains important.

Prostate health

TRT is contraindicated in men with known or suspected prostate cancer. For men without prostate cancer, current evidence does not support TRT as a cause of prostate cancer — but PSA monitoring is standard practice.

Polycythemia (elevated red blood cells)

TRT can increase hematocrit, which raises blood viscosity and clotting risk. This is one of the most important reasons for regular lab monitoring — hematocrit is checked routinely and dosing adjusted if needed.

Fertility

Exogenous testosterone suppresses the body's own testosterone production and can significantly reduce sperm count. Men who want to preserve fertility should discuss this with their provider before starting TRT.

Sleep apnea

TRT can worsen obstructive sleep apnea. Untreated sleep apnea is a relative contraindication — it should be evaluated and managed before or alongside TRT.

Who shouldn't use TRT.

Men with known or suspected prostate or breast cancer
Men with untreated severe sleep apnea
Men with significantly elevated hematocrit (polycythemia)
Men actively trying to conceive (without fertility-preserving protocols)
Men with certain cardiovascular conditions — evaluated case by case

Why monitoring isn't optional.

The risks of TRT are manageable — but only when they're being tracked. Regular labs (typically every 3–6 months) monitor testosterone levels, hematocrit, PSA, and other markers.

Dosing is adjusted based on results. If a marker moves in the wrong direction, treatment is modified or paused. That's how responsible TRT works.

HelloTRT is built on 1010Rx's clinical infrastructure. Monitoring isn't an add-on — it's part of the program.

Common questions.

Want to know if TRT is appropriate for you?

It starts with an honest evaluation — labs, history, and a licensed physician. Not a quiz.

Take the Low-T Check